Senior insider sale
SVP, CRO at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$5.73M
12.20K shares
TATSIS OURANIA plans to sell 12.20K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $5.73M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Vesting
Compensation
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/24/2026 | Restricted Stock Vesting Compensation | 260.00 | — |
| Total | 260.00 | ||
Completed
Units to sell
368.00
Market value
$174.3K
Units to sell
609.00
Market value
$298.1K
Units to sell
1.50K
Market value
$750.0K
Units to sell
466.00
Market value
$214.6K
Units to sell
4.50K
Market value
$2.14M
Units to sell
4.50K
Market value
$2.02M
Planned — Approximate Date
Units to sell
260.00
Market value
$126.5K
Units
12.20K
Value
$5.73M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/18/2026 | 368.00 | $174.3K | — | Completed |
2/17/2026 | 609.00 | $298.1K | — | Completed |
2/13/2026 | 1.50K | $750.0K | — | Completed |
2/11/2026 | 466.00 | $214.6K | — | Completed |
1/7/2026 | 4.50K | $2.14M | — | Completed |
12/3/2025 | 4.50K | $2.02M | — | Completed |
| Planned — Approximate Date | ||||
2/25/2026 | 260.00 | $126.5K | NASDAQ | Planned |
| Total | 12.20K | $5.73M | ||